Categories
Health

Maker of Speedy Covid Assessments Informed Manufacturing unit to Destroy Stock

Aly Morici, Abbott’s director of public affairs, rose to the challenge in the US, saying in an email that “it is difficult to scale to a dime, but we’re doing it again”. She admitted that “there will be some delivery bottlenecks in the coming weeks”.

Abbott invited workers back to the Maine facility this month to meet what a letter described as “unexpected production needs”. However, it is unclear how many employees will be returning. They would forego weeks of non-work remuneration, as provided for in their severance payments, with only a two-week “thank you” salary extension and no guarantee that their job would last.

The company wasn’t in that position in early 2020. In anticipation of fast, reliable testing that did not require specialized equipment, Abbott assembled a team of approximately 100 scientists, supply chain experts, and engineers to develop BinaxNOW in a highly compressed timeframe. The company took risks, imported expensive equipment, and opened two US factories. “Everyone’s been working non-stop,” said Mr. Ford. “That’s what Abbott was built for, in the end.”

The test strip, which is similar to the one on a stretch stick, is less sensitive than the PCR, but provides instant results so a company or school can react immediately.

The FDA granted BinaxNOW emergency approval last August. A day later, the U.S. government announced it would buy 150 million of the tests for $ 760 million – $ 5 per test plus shipping – to be used in facilities such as nursing homes and schools.

Washington’s Friendship Public Charter School received 20,000 government-purchased BinaxNOW tests for free as part of a pilot program supported by the Rockefeller Foundation. Patricia A. Brantley, the school’s general manager, said 70 percent of students’ parents chose to have them wiped once a week. “Testing is still an important part of the strategy to not only reopen schools but keep them open,” said Ms. Brantley.

Northwestern University also introduced BinaxNOW early on and tested the students twice a week. The university was running up to 5,000 rapid tests a day, according to Luke Figora, vice president of operations at the school.

Categories
Business

Excessive costs, few reductions and low stock await automotive customers

Daniel Acker | Bloomberg | Getty Images

Car shoppers hoping to cash in on Memorial Day weekend sales events may want to rein in their expectations.

On top of reduced inventory due to a shortage of microchips — key parts needed for today’s autos to operate — and unrelenting consumer demand pushing prices higher, there are fewer incentives being offered by manufacturers and dealers.

The average incentive is $2,957, down from $4,825 in May 2020 and $3,878 in May 2019, according to a new forecast from J.D. Power and LMC Automotive.

“People will be in for a bit of a surprise,” said Ivan Drury, senior manager of insights at Edmunds.com. “There will be little to no negotiation on price.

“We’re seeing more people pay sticker price or above.”

At the start of the pandemic more than a year ago, when dealerships and manufacturing plants were shut down, chipmakers pivoted to focusing on the consumer electronics industry — i.e., computers and gaming consoles — and there are still kinks in their ability to meet the renewed demand from automakers.

Some automakers have idled manufacturing plants or cut back production of certain models, or stopped including certain high-end packages — things like navigation systems or blind-spot detectors — in vehicles that typically would have them, Drury said. 

“The shortage is really kicking the legs out from under the industry,” Drury said.

More from Personal Finance:
Inflation worries? Retirees may want to consider this investment
Banks to offer credit cards to people without credit scores
Take these 5 steps to bulk up your emergency savings

In May, an estimated 33% of vehicles are selling within 10 days of arriving at a dealership, according to new estimates from J.D. Power and LMC Automotive. That compares to 18% selling that fast in May 2019.

Additionally, car shoppers may struggle to find the car they really want. To that point, 40% of car shoppers say they’re facing that problem, according to a recent survey from Cars.com.

“If you’re picky, this may not be the right time to buy,” Drury said. “But if you’re open-minded … you’ll be in a better position.”

Of course, it’s uncertain when the squeeze on inventory will lessen.

“By the end of year, things will start to improve,” Drury said. “But we’ll be nowhere near normal levels.”

The average price paid for a new car is close to $40,000, according to Edmunds.com. For used cars, it’s above $23,000. Some of the increase in prices are due to consumer preferences shifting over the last decade to pricier pickup trucks and SUVs and away from lower-priced sedans and small cars. Improved technology and safety features add to the price, as well.

Discounts are averaging about 7% or 8%, said Kelsey Mays, assistant managing editor for Cars.com. That compares to past years when that average was 10% to 12%.

Among the incentives being offered: The Chevrolet Silverado 1500, which starts at about $29,000, has a decent discount of around $4,000, depending on the trim level, Mays said. The Toyota Camry, with a starting price of about $25,000, may come with a $1,000 discount, depending on the specifics.

The silver lining to the higher cost for used cars is that trade-ins are worth more, as well. And while there may be little price negotiation for the car you’re buying, you may be able to get more for your trade-in to bring down the amount you have to finance.

“Potential wiggle room for consumers is going to be with their trade-in,” said Mays at Cars.com. “Consumers should leverage those elevated values and get the most they can.”

There are also other ways to bring down the cost of your purchase. Depending on your credit score, you may be able to find a 0% (or close to it) financing deal on a new car. Otherwise, the average interest rate paid on a five-year new-car loan is 4.12%, according to Bankrate. For a three-year used car loan, it’s 4.42%.

“Shop the interest rate,” Drury said. “That’s where savings can come from.”

If you’re picky, this may not be the right time to buy. But if you’re open-minded … you’ll be in a better position.

Ivan Drury

Senior manager of insights at Edmunds.com

Unless paying with cash, you should get preapproved for a loan from a bank or credit union. While there’s no obligation to use the preapproval, you’ll at least be armed with a comparison when the dealership offers its loan terms.

Be aware that the longer you stretch out your loan — say, for 72 or 84 months — in an effort to afford the monthly payments, the more you’ll pay in interest (unless it’s 0%) and the greater the chance that you’ll end up trading in your car for a new one before you’ve paid it off.

And in that scenario, if the trade-in value is less than what’s owed on the loan, consumers often end up rolling that “negative equity” into the loan for their next car.

If you want a brand-new car but can’t find exactly what you want, you may want to consider leasing instead of making a purchase.

“It’s not a long-term commitment … and might be better than financing something over six years that you don’t like,” Drury said.

Categories
Health

J&J doesn’t have massive stock of doses, Biden official says

Illustration of the Johnson & Johnson coronavirus vaccine

Given Ruvic | Reuters

Johnson & Johnson will not hold a “large inventory” of its Covid-19 vaccine until regulatory approval expected this month, President Joe Biden’s Covid tsar said Wednesday.

Jeff Zients said the government has learned in recent weeks that J&J will only manufacture “a few million” doses if its single vaccine is likely to be approved by the Food and Drug Administration.

Federal and state health officials expected vaccine supplies to increase rapidly once the J&J emergency vaccine was approved. The FDA scheduled a meeting of its Advisory Committee on Vaccines and Related Biological Products on February 26th to discuss the vaccine. The US could approve the vaccine the next day.

J&J currently has a contract with the U.S. government to deliver 100 million doses of its vaccine by the end of June, said Zients, the president’s Covid-19 response coordinator. Assuming the vaccine is approved, the Biden government will work with J&J to increase supply as soon as possible. US officials hope many of these cans will be available in the first few months of their introduction.

“We are doing everything we can to work with the company and accelerate the delivery schedule,” Zients told reporters during a White House press conference on the pandemic.

The news comes as the Biden government works to increase the supply of cans after states complained that demand for the shots was rapidly exceeding supply. Around 39.7 million out of roughly 331 million Americans have received at least their first dose of Pfizer’s or Moderna’s two-dose vaccines, according to the Centers for Disease Control and Prevention. And 15 million of those people have already got their second shot.

Biden announced Thursday that the US has received 100 million more doses of the Pfizer BioNTech vaccine and 100 million more of the Moderna vaccine, bringing the total US supply to 600 million doses. Since the vaccines require two doses, a total of 600 million doses would be enough to vaccinate 300 million Americans.

On Tuesday, White House Press Secretary Jen Psaki announced that the Biden administration is increasing the number of Covid-19 vaccine doses sent weekly to states, shipping 13.5 million doses this week and doubling the number of pharmacies sold to pharmacies.

Dr. Anthony Fauci said Tuesday that most Americans will have access to a Covid-19 vaccine by mid to late May or early June, a slight delay compared to previous predictions made in late March and April.

The White House chief medical officer said the federal government expects J&J to “significantly increase” starting doses.

“I’m a little disappointed that the number of doses we’re getting early from J&J is relatively small, but as we get further into spring there will be more and more,” said Fauci.

Meanwhile, Pfizer and Moderna are looking into whether their vaccines can prevent transmission of the virus, he said on Wednesday, adding that early studies point in a “favorable direction”.